SBIR/STTR Research Award
Database Resources Integration An integrated Biomedical Dataset discovery system for Immunological Research Databases
Award amount
$224,563Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INFOTECH SOFT, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- MA6JU9GF1EE3
- Solicitation number
- Not reported
- Topic code
- NIAID
Research abstract
The contractor will develop the Immunology Information Integration I platform I employs an ontology based data model to index query and virtualize data metadata knowledge and tools of the DAIT repositories I relies on GeneTegra data source models which are representations of the data schema codified in the Web Ontology Language OWL A user interface will be developed to prototype integrated data query retrieval and analyses The Contractor will work with the expert consultant team in defining common workflows identifying the tools needed for such workflows to be executed and building tool and workflow descriptors within Galaxy
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- SBIR 136 - INFOTECH: Integrated Knowledge Spaces for Infectious and Immune-mediated Disease Research
- Deep-CDS: Deep Learning Semantic Data Lake for Clinical Decision Support
- Deep-CDS: Deep Learning Semantic Data Lake for Clinical Decision Support
- SBIR TOPIC 417: QUANTITATIVE IMAGING SOFTWARE TOOLS FOR CANCER DIAGNOSIS AND TREATMENT PLANNING
- Microbiome Meta-Analysis Platform
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
- A first-in-class product for the clearance of high-risk human papillomaviruses
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients
Research funding history
35 SBIR/STTR records share this UEI (1999–2024). Reported award amounts total $18,214,937. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services